25 of the Best Oncologists Near Me

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Reconstruction, and Nephrectomy. Dr. Hoffman is board certified in American Board Of Internal Medicine.

Sarah Nikiforow is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Nikiforow is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Hemophagocytic Lymphohistiocytosis, Non-Langerhans-Cell Histiocytosis, Graft Versus Host Disease (GvHD), Reticulohistiocytoma, and Bone Marrow Transplant. Dr. Nikiforow is board certified in Hematology.

James T. Handa, M.D., is Chief of the Retina Division and the Robert Bond Welch, M.D., Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in medical and surgical management of complex vitreoretinal diseases such as age-related macular degeneration, diabetic retinopathy, retinal detachment, retinopathy of prematurity and other pediatric retinal diseases. He also has expertise in intraocular oncology and manages patients with choroidal melanomas and metastatic tumors of the eye. Not only is he a highly skilled surgeon and clinician, but he also devotes significant effort to research related to the early causes of age-related macular degeneration using molecular pathological approaches to understand how the eye transforms from normal aging to early disease. He has been funded by the National Eye Institute for the last 19 years, and he currently holds two R01 awards for his work in AMD. He has also been funded by the Thome Foundation, Research to Prevent Blindness, Fight for Sight and the American Health Assistance Foundation. His other research focuses on surgical innovation using an integrated robotic surgical system. Dr. Handa is currently the Wilmer Eye Institute’s implanting surgeon for the Argus II retinal chip implant, which was recently approved by the FDA after Dr. Handa participated in the clinical trial leading to its approval. Dr. Handa is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma of the Eye, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Metastatic Uveal Melanoma, and Vitrectomy. Dr. Handa is board certified in American Board Of Ophthalmology.

Kathryn Mileham is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Mileham is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Mileham is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Mileham is currently accepting new patients.

David Lawson is an Oncologist practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 52 years. Dr. Lawson is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Brain Tumor, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET). Dr. Lawson is board certified in American Board Of Internal Medicine, 1979.

Jamie Lesnock, MD, specializes in gynecologic oncology and is certified in gynecologic oncology and obstetrics and gynecology by the American Board of Obstetrics and Gynecology. She practices at University of Pittsburgh Physicians, Department of Obstetrics and Gynecology and is affiliated with UPMC Mercy, UPMC Presbyterian, UPMC Shadyside, UPMC Magee-Womens Hospital, and UPMC Passavant. She completed her residency at University of Pittsburgh School of Medicine and her medical degree at Vanderbilt University School of Medicine. Dr. Lesnock is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Hysterectomy, and Ureteral Reconstruction. Dr. Lesnock is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Lesnock is currently accepting new patients.

As a blood cancer specialist and also a palliative care physician, I bring a different focus to cancer care. I’m working hard to improve the treatment experience for patients who are living with blood cancers. By understanding your experience better, we can develop new ways to improve your quality of life, and provide additional support throughout your treatment and beyond. Dr. Leblanc is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Leblanc is board certified in American Board Of Internal Med, Hospice & Palliative Medicine and American Board Of Internal Med, Medical Oncology.

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer. Dr. Alistar is board certified in American Board Of Internal Medicine. Dr. Alistar is currently accepting new patients.

David Vanderweele is a Hematologist and an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 19 years. Dr. Vanderweele is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Prostatectomy. Dr. Vanderweele is board certified in American Board Of Internal Medicine - Medical Oncology (Certified).

Jun Zhang is an Oncologist practicing medicine in Peoria, Illinois. Dr. Zhang is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Squamous Cell Lung Carcinoma. Dr. Zhang is board certified in American Board Of Internal Medicine.

Sara Parylo is a Hematologist practicing medicine in Oneonta, New York. Dr. Parylo is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Leukocytosis, and Small Cell Lung Cancer (SCLC). Dr. Parylo is board certified in American Board Of Internal Medicine.

Dr. Yonette Paul’s passion to work in the field of hematology/oncology was ignited during her first job. She was working in the lab for a hematology/oncology practice when she felt the pull to be on the front lines in the field as a physician. It was not long before she quit her job and headed to medical school in Jamaica, near the Caribbean island of St. Lucia, where she grew up. After earning medical degrees in medicine and surgery, she traveled to the U.S. to further her studies in hematology/oncology. Dr. Paul completed an internal medicine residency at Howard University Hospital in Washington, D.C., and a fellowship in hematology/oncology at University of Miami/Jackson Memorial Hospital in Miami, Florida. “Throughout my training, my eye was on the goal of specializing in hematology/oncology,” she says. Now that she has realized her dream, she says what she most enjoys about her work is the interaction with her patients. “One thing I want my patients to know is that when we are together they are the most important person in the room,” she says. “I want them to know we will be a team from diagnosis all the way through treatment. I will be there to support them. I want to learn from them, and I hope they will learn from me.” Keeping patients engaged in their treatment is one of Dr. Paul’s main goals. “I want them to let me know what they want as an outcome, not just wait for me to tell them what to do. I find that listening to them is the best way to find out what they want for themselves,” she says. Moving to the Appalachian Highlands region with her husband to join Ballad Health Cancer Care in Kingsport was a welcome relief from the hustle-bustle of larger cities, she says. “I fell in love with th[e beauty here. People are friendly and welcoming. And, when I look out my window and see the mountains, I’m reminded of home.”. Dr. Paul is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Thrombocytopenia, Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, and Lung Adenocarcinoma. Dr. Paul is board certified in American Board Of Internal Medicine.

Dr. Shah is a multiple time recipient of the Seattle Magazine and Seattle Metropolitan Magazine Top Doctor Award including the Seattle Metropolitan Best of the Best Top Doctor Designation. Dr. Shah endeavors to provide comprehensive, thoughtful and dedicated level of care to women with or at risk for gynecologic cancers and their families. As a gynecologic oncologist, he is in the unique position of being able to provide comprehensive, personalized care. Whether a condition calls for surgery, chemotherapy or radiation treatment, Dr. Shah aims to be the primary care provider for a woman’s oncologic concerns. Having completed training in advanced surgical techniques (including robotic surgery), radical abdominal procedures and cutting-edge research, his goal is to treat his patients with the most current, effective and state-of-the-art treatment options available. Dr. Shah is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Malignant Mixed Mullerian Tumor, Ovarian Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Shah is board certified in American Board Of Obstetrics And Gynecology. Dr. Shah is currently accepting new patients.

Raymond Osarogiagbon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Southaven,, Mississippi. Dr. Osarogiagbon is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Lung Adenocarcinoma, and Endoscopy.

I enjoy traveling, dancing and food. Dr. Shroff is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Shroff is board certified in American Board Of Internal Medicine/Medical Oncology. Dr. Shroff is currently accepting new patients.

Kevin Kalinsky is an Oncologist practicing medicine in Atlanta, Georgia. Dr. Kalinsky is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, and Inflammatory Breast Cancer.

William Gradishar is an Oncologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 44 years. Dr. Gradishar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and PIK3CA-Related Overgrowth Spectrum. Dr. Gradishar is board certified in American Board Of Internal Medicine - Internal Medicine (Certified).

Manisha Bhutani is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Bhutani is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bhutani is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine, Hematology. Dr. Bhutani is currently accepting new patients.

Allen Cohn is an Oncologist practicing medicine in Denver, Colorado. Dr. Cohn is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Neuroendocrine Tumor, Pancreatic Cancer, Lymphadenectomy, and Tissue Biopsy. Dr. Cohn is board certified in American Board Of Internal Medicine. Dr. Cohn is currently accepting new patients.

Dr. Irina Murakhovskaya is an Assistant Professor of Medicine (Hematology). She completed a medical degree at Albert Einstein College of Medicine and residency and fellowship training at Montefiore Health System. Her clinical interests focus on monoclonal gammopathy, low-grade lymphoma, and hematologic issues in pregnancy. Dr. Murakhovskaya is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Autoimmune Hemolytic Anemia, Thrombocytopenia, Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.

Elizabeth Reed is an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 46 years. Dr. Reed is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Endoscopy.

My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and Metastatic Brain Tumor.

Josephine (Joy) Feliciano, M.D., is an assistant professor of oncology at The Johns Hopkins University School of Medicine and a faculty member of the Johns Hopkins Kimmel Cancer Center. She serves as medical director of the Thoracic Oncology Program at Johns Hopkins Bayview Medical Center, as well as co-director of the outpatient oncology clinic at Johns Hopkins Bayview. Dr. Feliciano completed both undergraduate and postgraduate medical training at Georgetown University, as well as residency training, where she was selected as chief resident. She spent three years at Northwestern completing clinical training in hematology and oncology, then joined the faculty at University of Maryland Greenberg Cancer Center. At the University of Maryland, Feliciano focused on lung cancer screening and health disparities research for patients with lung cancer. While there, she also earned a certificate degree in the Epidemiology and Human Genetics Program for Clinical Investigation. Dr. Feliciano is also a member of the Miller Coulson Academy of Clinical Excellence. She also serves as the inaugural Medical Director of the Sidney Kimmel Cancer Diagnostic and Treatment Planning Center. Dr. Feliciano is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Feliciano is board certified in American Board Of Internal Medicine.

Leonard Gomella is an Oncologist and a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Gomella is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Gomella is board certified in Urology. Dr. Gomella is currently accepting new patients.

Stéphanie Gaillard is a medical oncologist who specializes in the treatment of gynecologic malignancies. She recently joined the faculty of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and is their Director of Gynecologic Cancer Trials. Dr. Gaillard earned her medical degree and doctoral degree in cancer biology from Duke University. Following medical school, she underwent residency training in Internal Medicine and fellowship training in Medical Oncology at the Johns Hopkins School of Medicine. Dr. Gaillard’s research focuses on the development of clinical trials aimed at improving outcomes by incorporating promising new biologic, targeted, and immune therapies into standard treatment regimens. Her translational research program focuses on understanding the immune environment associated with gynecologic cancers and mechanisms of resistance to current therapies. Dr. Gaillard is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Tissue Biopsy, and Salpingo-Oophorectomy. Dr. Gaillard is board certified in American Board Of Internal Medicine.